Dermatology is a broad, fast-moving field. From eczema to metastatic melanoma, our team of experts has the experience needed to help product developers accelerate innovation and enrich the likelihood of trial success: https://lnkd.in/eSEtb6aZ #DrugDevelopment #ClinicalResearch #Dermatology #ClinicalTrials
Premier Research’s Post
More Relevant Posts
-
The dermatology clinical trial landscape is a competitive one. That is why you need a trusted clinical research partner with strong site relationships and patient engagement experience. Read the fact sheet to learn how Advanced Clinical can support your study: https://hubs.la/Q02hBjX50 #dermatology #dermatologystudy #clinicalresearch #clinicalstudy
-
-
Director of Dermatopathology & Dermatologist with a great breadth of expertise contributing to advances in Dermatopathology, Immunodermatology, patient care, education, research, & healthcare policy.
Excited to be speaking at #AADInnovation2024 on "Clinching the Diagnosis: Dermpath, CPC, Testing & Beyond and Co-Directing Innovations in Dermatopathology." Join me as we explore cutting-edge advancements in the field that are reshaping how we diagnose and manage skin conditions and tumors. Looking forward to sharing insights and discussing the future of dermatopathology with fellow experts! 🌟 See you in Seattle! #Dermatology #MedicalInnovation #SkinHealth American Academy of Dermatology Northwell Health #dermatopathology #dermatology #precisionmedicine
-
-
Have you considered using Raster-scan optoacoustic mesocopy (RSOM) in your dermatology clinical trial? Here are three main reasons why RSOM improves your clinical trial in dermatology drug development: #molecularmonday #RSOM #skin #melanoma #atopicdermatitis #drugdevelopment #dermatology
-
-
Our CMO, Dr. Stefan Weiss, sat down with Lauren Buchanan of Dermatology Times to discuss the advantages of our technology and the promising results from our Phase 1b Clinical Trial in #psoriasis. Our oral therapeutic candidate shows great potential in reducing pro-inflammatory cytokines and achieving high PASI clearance rates – essential criteria for advancing the treatment into further trial phases. Read the article here: https://lnkd.in/gfTCdsYX #ClinicalTrials #Dermatology #OralTherapeutics
-
-
🎧 Tune into our podcast episode exploring the unique aspects of dermatology in clinical trials. Dive into the challenges, innovations, and the future of this therapeutic area. A must-listen for anyone passionate about advancing dermatology care! https://hubs.li/Q02pwXry0 #clinicaltrials #dermatology #clinicalinnovations
-
-
Skin Cancer Breakthroughs, Prevention, and Treatment Advances During the Past Year: Now available on Dermatology Times at https://lnkd.in/gh53VhCt "A recent study found that the combination of dermoscopy with reflectance confocal microscopy enhanced the diagnostic accuracy of amelanotic/hypomelanotic lentigo maligna/lentigo maligna melanoma, aiding dermatologists in accurately identifying skin lesions and improving patient outcomes." #DNA #SkinCancerAwarenessMonth #ContinuingEducation #Dermatology #Skincare #Healthcare #OneForAll #GrowthIsInOurDNA #DermNurses #Nursing
-
-
In the latest HCPLive feature, 3 experts in the fields of dermatology and rheumatology discussed harnessing patient insights in the management of psoriasis and psoriatic arthritis. One such expert was Amanda Mixon, PA-C, a physician assistant at UCHealth and co-founder of Rheumatology Advance Practice Providers (RhAPP) who highlighted her views on the topic. View the full feature here: https://lnkd.in/eqtC5xrc #Dermatology #Rheumatology
-
-
🚀 Calling all clinical trial sponsors! Looking for high-performing sites for your next #dermatology study? Choose Probity Medical Research for unparalleled access to a vast network of top-tier sites ready to elevate your research to the next level. Partner with us and experience excellence in dermatology trials! 🌟 #ClinicalTrials #ClinicalResearch #DermatologyResearch #HighPerformance #ProbityMedicalResearch #HealthcareInnovation #ClinicalSitePartnership #PMRConnect
-
-
Knock out psoriasis 🥊💥 This morning at the late breaker session at the American Academy of Dermatology annual meeting, Dr. Andy Blauvelt presented results for high induction dose of risankizumab. Patients received the IL-23 inhibitor at weeks 0, 4, and 16 with no further treatment. Results showed sustained response through 52 weeks! Future of psoriasis? Check out the clip below and let us know what you think. #psoriasis #aad2024 #dermatology
-
October is Eczema Awareness Month 🌎 a key time to explore groundbreaking treatments in pediatric atopic dermatitis (AD). One such advancement is Aryl hydrocarbon receptor (AhR) agonist therapy, showing promising results by: 1️⃣ Effectively reducing atopic lesions and itching 2️⃣ Offering a rapid onset of action 3️⃣ Enhancing quality of life without the safety concerns of long-term steroid use Originally presented at the 32nd Annual Masters of Pediatric Dermatology conference, this educational activity provides key insights for clinicians. Missed the live event? Don't worry—you can still access expert discussions, medical animations, and the latest clinical evidence! 💡 🔗Register here: https://lnkd.in/exY5x4Ty #LiVDerm #MastersofPediatricDermatology #EczemaAwarenessMonth #AtopicDermatitis #Dermatology #CME #CE
-
Felix Perez, CEO Research Director
3moYour expertise in dermatology research is invaluable for advancing treatment innovations. Keep driving progress in clinical trials!